{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T10:51:13Z","timestamp":1789555873226,"version":"build-2803163510"},"reference-count":63,"publisher":"Elsevier BV","issue":"6-7","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.annder.2016.02.018","type":"journal-article","created":{"date-parts":[[2016,3,28]],"date-time":"2016-03-28T10:15:34Z","timestamp":1459160134000},"page":"423-435","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Aplasie cutan\u00e9e cong\u00e9nitale et antithyro\u00efdiens de synth\u00e8se au cours de la grossesse\u00a0: s\u00e9rie de cas et revue de la litt\u00e9rature"],"prefix":"10.1016","volume":"143","author":[{"given":"C.","family":"Sachs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Tebacher-Alt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Cribier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Lipsker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.annder.2016.02.018_bib0320","doi-asserted-by":"crossref","first-page":"60","DOI":"10.7326\/0003-4819-106-1-60","article-title":"Methimazole, carbimazole, and congenital skin defects","volume":"106","author":"Van Dijke","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.annder.2016.02.018_bib0325","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S0190-9622(86)70082-0","article-title":"Aplasia cutis congenita: a clinical review and proposal for classification","volume":"14","author":"Frieden","year":"1986","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.annder.2016.02.018_bib0330","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/dth.12106","article-title":"Aplasia cutis congenita: approach to evaluation and management","volume":"26","author":"Browning","year":"2013","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.annder.2016.02.018_bib0335","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1007\/s00381-002-0654-4","article-title":"Aplasia cutis congenita of the scalp","volume":"18","author":"Mart\u00ednez-Lage","year":"2002","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/j.annder.2016.02.018_bib0340","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1471-0528.2004.00347.x","article-title":"Aplasia cutis congenita and low molecular weight heparin","volume":"112","author":"Sharif","year":"2005","journal-title":"BJOG"},{"key":"10.1016\/j.annder.2016.02.018_bib0345","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/j.1651-2227.1994.tb13143.x","article-title":"Aplasia cutis congenita of the scalp in an infant exposed to valproic acid in utero","volume":"83","author":"Hubert","year":"1994","journal-title":"Acta Paediatr"},{"key":"10.1016\/j.annder.2016.02.018_bib0350","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1002\/art.34419","article-title":"Pregnancy outcome in women exposed to leflunomide before or during pregnancy","volume":"64","author":"Cassina","year":"2012","journal-title":"Arthritis Reum"},{"key":"10.1016\/j.annder.2016.02.018_bib0355","first-page":"782","article-title":"Aplasia cutis associated with azathioprine","volume":"59","author":"Iftikhar","year":"2009","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/j.annder.2016.02.018_bib0360","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1002\/tera.1420050117","article-title":"Maternal methimazole and congenital defects in children","volume":"5","author":"Milham","year":"1972","journal-title":"Teratology"},{"key":"10.1016\/j.annder.2016.02.018_bib0365","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/tera.1420320221","article-title":"Scalp defects in infants of mothers treated for hyperthyroidism with methimazole or carbimazole during pregnancy","volume":"32","author":"Milham","year":"1985","journal-title":"Teratology"},{"key":"10.1016\/j.annder.2016.02.018_bib0370","first-page":"282","article-title":"Treatment of hyperthyroidism in pregnancy with propylthiouracil and methimazole","volume":"46","author":"Mujtaba","year":"1975","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annder.2016.02.018_bib0375","first-page":"539","article-title":"Thyrotoxicosis in pregnancy, a six-year review","volume":"30","author":"Lim","year":"1989","journal-title":"Singapore Med J"},{"key":"10.1016\/j.annder.2016.02.018_bib0380","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/(SICI)1096-8628(19990305)83:1<43::AID-AJMG8>3.0.CO;2-C","article-title":"Methimazole embryopathy: delineation of the phenotype","volume":"83","author":"Clementi","year":"1999","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.annder.2016.02.018_bib0385","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/tera.1096","article-title":"Teratogen update: antithyroid drugs methimazole, carbimazole, and propylthiouracil","volume":"65","author":"Diav-Citrin","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.annder.2016.02.018_bib0390","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.30418","article-title":"Carbimazole embryopathy: an emerging phenotype","volume":"132A","author":"Foulds","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.annder.2016.02.018_bib0395","doi-asserted-by":"crossref","first-page":"E337","DOI":"10.1210\/jc.2010-0652","article-title":"Treatment of hyperthyroidism in pregnancy and birth defects","volume":"95","author":"Clementi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.annder.2016.02.018_bib0400","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/ajmg.a.33705","article-title":"Grade 1\u00a0microtia, wide anterior fontanel and novel type tracheo-esophageal fistula in methimazole embryopathy","volume":"155","author":"Gripp","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.annder.2016.02.018_bib0405","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/qjmed\/hcq248","article-title":"Carbimazole embryopathy: implications on the choice of antithyroid drugs in pregnancy","volume":"105","author":"Bowman","year":"2012","journal-title":"Q J Med"},{"key":"10.1016\/j.annder.2016.02.018_bib0410","doi-asserted-by":"crossref","first-page":"2390","DOI":"10.1002\/ajmg.a.32497","article-title":"Choanal atresia associated with maternal hyperthyroidism treated with methimazole: a case-control study","volume":"146","author":"Barbero","year":"2008","journal-title":"Am J Med Genet A"},{"key":"10.1016\/j.annder.2016.02.018_bib0415","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-14-0135","article-title":"Antithyroid drug use in early pregnancy and birth defects: time windows of relative safety and high risk?","volume":"171","author":"Laurberg","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.annder.2016.02.018_bib0420","doi-asserted-by":"crossref","first-page":"4373","DOI":"10.1210\/jc.2013-2831","article-title":"Birth defects after early pregnancy use of antithyroid drugs: a Danish nationwide study","volume":"98","author":"Andersen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.annder.2016.02.018_bib0425","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of grave's disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.annder.2016.02.018_bib0430","first-page":"111","article-title":"Imputation of the unexpected or toxic effects of drugs. Actualization of the method used in France","volume":"40","author":"B\u00e9gaud","year":"1985","journal-title":"Therapie"},{"key":"10.1016\/j.annder.2016.02.018_bib0435","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1002\/bdra.23117","article-title":"Carbimazole embryopathy in a Chinese population: case series and literature review","volume":"97","author":"Ting","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.annder.2016.02.018_bib0440","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.ando.2010.07.001","article-title":"Malformations cong\u00e9nitales observ\u00e9es au cours d\u2019un traitement maternel par carbimazole\u00a0: six cas notifi\u00e9s au centre r\u00e9gional de pharmacovigilance de Nice","volume":"71","author":"Koenig","year":"2010","journal-title":"Ann Endocrinol"},{"key":"10.1016\/j.annder.2016.02.018_bib0445","doi-asserted-by":"crossref","first-page":"235130","DOI":"10.4061\/2011\/235130","article-title":"Suspected spontaneous reports of birth defects in the UK associated with the use of carbimazole and propylthiouracil in pregnancy","volume":"2011","author":"Bowman","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.annder.2016.02.018_bib0450","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1525-1470.2011.01572.x","article-title":"Aplasia cutis congenita and other anomalies associated with methimazole exposure during pregnancy","volume":"28","author":"Rodr\u00edguez-Garc\u00eda","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2016.02.018_bib0455","first-page":"215","article-title":"Aplasia cutis congenita in surviving co-twin after propylthiouracil exposure in utero","volume":"24","author":"L\u00f6llgen","year":"2011","journal-title":"J Pediatr Endocr Met"},{"key":"10.1016\/j.annder.2016.02.018_bib0460","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.arcped.2010.02.017","article-title":"Un nouveau ph\u00e9notype possible d\u2019embryopathie au carbimazole\u00a0: \u00e0 propos d\u2019une observation","volume":"17","author":"Mellerio","year":"2010","journal-title":"Arch Pediatr"},{"key":"10.1016\/j.annder.2016.02.018_bib0465","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1002\/bdra.20395","article-title":"Aplasia cutis congenita with skull defect in a monozygotic twin after exposure to methimazole in utero","volume":"79","author":"Iwayama","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.annder.2016.02.018_bib0470","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1515\/JPEM.2007.20.5.585","article-title":"Aplasia cutis congenita following in utero methimazole exposure","volume":"20","author":"Baid","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/j.annder.2016.02.018_bib0475","doi-asserted-by":"crossref","first-page":"312","DOI":"10.4103\/0028-3886.27165","article-title":"Aplasia cutis congenita of the scalp: therapeutic modalities","volume":"54","author":"Shivakumar","year":"2006","journal-title":"Neurol India"},{"key":"10.1016\/j.annder.2016.02.018_bib0480","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2169\/internalmedicine.44.1202","article-title":"Aplasia cutis congenita and skull defects after exposure to methimazole in utero","volume":"44","author":"Nakamura","year":"2005","journal-title":"Intern Med"},{"key":"10.1016\/j.annder.2016.02.018_bib0485","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/j.0736-8046.2004.21417.x","article-title":"Aplasia cutis congenita after methimazole exposure in utero","volume":"21","author":"Karg","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2016.02.018_bib0490","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1002\/bdra.10098","article-title":"Malformations following methimazole exposure in utero: an open issue","volume":"67","author":"Ferraris","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.annder.2016.02.018_bib0495","first-page":"526","article-title":"Aplasia cutis congenita and antithyroid drugs","volume":"52","author":"Izhar","year":"2002","journal-title":"J Park Med Assoc"},{"key":"10.1016\/j.annder.2016.02.018_bib0500","first-page":"290","article-title":"Aplasia cutis como efecto terat\u00f3geno del metimazol","volume":"51","author":"D\u00edez-Delgado Rubio","year":"1999","journal-title":"Ann Esp Pediatr"},{"key":"10.1016\/j.annder.2016.02.018_bib0505","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1111\/j.1365-2133.1995.tb06940.x","article-title":"Aplasia cutis congenita after exposure to methimazole: a causal relationship?","volume":"133","author":"Vogt","year":"1995","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.annder.2016.02.018_bib0510","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1089\/thy.1994.4.129","article-title":"Review of antithyroid drug use during pregnancy and report of a case of aplasia cutis","volume":"4","author":"Mandel","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/j.annder.2016.02.018_bib0515","first-page":"575","article-title":"Aplasia cutis apr\u00e8s exposition in utero au carbimazole","volume":"20","author":"Dutertre","year":"1991","journal-title":"J Gynecol Obstet Biol Reprod"},{"key":"10.1016\/j.annder.2016.02.018_bib0520","first-page":"996","article-title":"Elevated alpha-fetoprotein in pregnancy complicated by aplasia cutis after exposure to methimazole","volume":"71","author":"Farine","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.annder.2016.02.018_bib0525","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1525-1470.1986.tb00534.x","article-title":"The association of aplasia cutis congenita with therapy of maternal thyroid disease","volume":"3","author":"Kalb","year":"1986","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.annder.2016.02.018_bib0530","first-page":"1264","article-title":"Aplasia cutis congenita and methimazole","volume":"130","author":"Bachrach","year":"1984","journal-title":"Can Med Assoc J"},{"key":"10.1016\/j.annder.2016.02.018_bib0535","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1515\/jpm.2011.089","article-title":"Aplasia cutis congenita due to methimazol exposure within the first trimester of pregnancy: case report","volume":"39","author":"Akar","year":"2011","journal-title":"J Perinat Med"},{"issue":"3","key":"10.1016\/j.annder.2016.02.018_bib0540","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1111\/j.1365-4632.2009.04254.x","article-title":"Aplasia cutis congenita after methimazole exposure in utero successfully treated with basic fibroblast growth factor","volume":"49","author":"Abe","year":"2010","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.annder.2016.02.018_bib0545","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1096-8628(20001002)94:4<338::AID-AJMG13>3.0.CO;2-6","article-title":"Ectodermal abnormalities associated with methimazole intrauterine exposure","volume":"94","author":"Martin-Denavit","year":"2000","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.annder.2016.02.018_bib0550","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0028-2243(94)90276-3","article-title":"Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy","volume":"183","author":"Kriplani","year":"1994","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.annder.2016.02.018_bib0555","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, antithyroid mediction use, and complications among pregnant women in the United States","volume":"23","author":"Korelitz","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/j.annder.2016.02.018_bib0560","series-title":"Endotext [Internet]","article-title":"Hyperthyroidism in pregnancy","author":"Okosieme","year":"2000"},{"key":"10.1016\/j.annder.2016.02.018_bib0565","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9378(13)70286-2","article-title":"A comparaison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy","volume":"170","author":"Wing","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.annder.2016.02.018_bib0570","first-page":"3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placenta lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.annder.2016.02.018_bib0575","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1002\/tera.1072","article-title":"Adverse effets of prenatal methimazole exposure","volume":"64","author":"Di Gianantonio","year":"2001","journal-title":"Teratology"},{"key":"10.1016\/j.annder.2016.02.018_bib0580","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1155\/2013\/878467","article-title":"Management of hyperthyroidism in pregnancy: comparison of recommendations of American thyroid association and endocrine society","volume":"2013","author":"Alamdari","year":"2013","journal-title":"J Thyroid Res"},{"key":"10.1016\/j.annder.2016.02.018_bib0585","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1186\/1687-9856-2009-132041","article-title":"Propylthiouracil hepatoxicity in children and recommendations for discontinuation of use","volume":"2009","author":"Rivkees","year":"2009","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/j.annder.2016.02.018_bib0590","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1016\/S1701-2163(16)35438-X","article-title":"The safety of methimazole and propylthiouracil in pregnancy: a systematic review","volume":"34","author":"Hackmon","year":"2012","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.annder.2016.02.018_bib0595","doi-asserted-by":"crossref","first-page":"e0126610","DOI":"10.1371\/journal.pone.0126610","article-title":"Congenital anomalies in children exposed to antithyroid drugs in utero: a meta-analysis of cohort studies","volume":"10","author":"Li","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2016.02.018_bib0600","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/0140-6736(92)90640-O","article-title":"Methimazole in animal feeds and congenital plasia cutis","volume":"339","author":"Mart\u00ednez-Fr\u00edas","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/j.annder.2016.02.018_bib0605","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/bdrb.21057","article-title":"Potential teratogenicity of methimazole: exposure of zebrafish embryos to methimazole causes similar developmental anomalies to human methimazole embryopathy","volume":"98","author":"Komoike","year":"2013","journal-title":"Birth Defects Res B Dev Reprod Toxicol"},{"key":"10.1016\/j.annder.2016.02.018_bib0610","doi-asserted-by":"crossref","first-page":"e23825","DOI":"10.1371\/journal.pone.0023825","article-title":"The thyroid hormone receptors modulate the skin response to retinoids","volume":"6","author":"Garc\u00eda-Serrano","year":"2001","journal-title":"PLoS One"},{"key":"10.1016\/j.annder.2016.02.018_bib0615","first-page":"793","article-title":"Dissection g\u00e9n\u00e9tique de la fonction de l\u2019acide r\u00e9tino\u00efque dans la physiologie de l\u2019\u00e9piderme","volume":"129","author":"Ghyselinck","year":"2002","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.annder.2016.02.018_bib0620","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1365-2265.1984.tb00119.x","article-title":"Maternal hyperthyroidism and congenital malformation in the offspring","volume":"20","author":"Momotani","year":"1984","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4\u00a0Suppl.","key":"10.1016\/j.annder.2016.02.018_bib0625","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1542\/peds.113.S3.1114","article-title":"Skin","volume":"113","author":"Mancini","year":"2004","journal-title":"Pediatrics"},{"key":"10.1016\/j.annder.2016.02.018_bib0315","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/bdra.23200","article-title":"Carbimazole\/methimazole embryopathy in siblings: a possible genetic susceptibility","volume":"97","author":"Goel","year":"2013","journal-title":"Birth Defects Res A Clin Mol Teratol"}],"container-title":["Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816001046?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0151963816001046?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T11:04:08Z","timestamp":1758971048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0151963816001046"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":63,"journal-issue":{"issue":"6-7","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S0151963816001046"],"URL":"https:\/\/doi.org\/10.1016\/j.annder.2016.02.018","relation":{},"ISSN":["0151-9638"],"issn-type":[{"value":"0151-9638","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aplasie cutan\u00e9e cong\u00e9nitale et antithyro\u00efdiens de synth\u00e8se au cours de la grossesse\u00a0: s\u00e9rie de cas et revue de la litt\u00e9rature","name":"articletitle","label":"Article Title"},{"value":"Annales de Dermatologie et de V\u00e9n\u00e9r\u00e9ologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.annder.2016.02.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}